Growth Metrics

Phibro Animal Health (PAHC) Gross Profit (2016 - 2026)

Phibro Animal Health has reported Gross Profit over the past 14 years, most recently at $132.7 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 30.22% year-over-year to $132.7 million; the TTM value through Dec 2025 reached $467.0 million, up 32.63%, while the annual FY2025 figure was $399.9 million, 27.74% up from the prior year.
  • Gross Profit for Q4 2025 was $132.7 million at Phibro Animal Health, up from $119.8 million in the prior quarter.
  • Over five years, Gross Profit peaked at $132.7 million in Q4 2025 and troughed at $64.7 million in Q3 2021.
  • A 5-year average of $84.4 million and a median of $77.9 million in 2022 define the central range for Gross Profit.
  • Biggest five-year swings in Gross Profit: fell 2.24% in 2023 and later surged 43.46% in 2025.
  • Year by year, Gross Profit stood at $70.7 million in 2021, then grew by 9.5% to $77.4 million in 2022, then rose by 1.59% to $78.6 million in 2023, then grew by 29.58% to $101.9 million in 2024, then skyrocketed by 30.22% to $132.7 million in 2025.
  • Business Quant data shows Gross Profit for PAHC at $132.7 million in Q4 2025, $119.8 million in Q3 2025, and $110.0 million in Q2 2025.